Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net loss	$ (2,638,133)	$ (2,845,813)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	12,395	12,267
Stock option compensation expense	8,260	49,181
Share-based compensation - common stock	1,900	2,125
Common stock and warrants issued to consultants		182,600
Debt discount amortization	705,758	265,358
Unrealized loss on derivative instruments	17,414	41,694
Loss on conversion of notes		2,588
Changes in assets and liabilities:
Receivables	30,330	(183)
Prepaid expenses and other current assets	52,524	191,249
Inventory	80,000	40,000
Accounts payable, accrued expenses and other liabilities	486,623	936,494
Deferred revenue		(13,286)
Net cash used in operating activities	(1,242,929)	(1,135,726)
Cash flows from investing activities:
Purchase of property and equipment		(4,700)
Net cash used in investing activities		(4,700)
Cash flows from financing activities:
Proceeds from notes payable	1,200,000	857,000
Repayment of note and warrant settlement		(42,500)
Proceeds from common stock and warrants		365,000
Net cash provided by financing activities	1,200,000	1,179,500
Net increase (decrease) in cash	(42,929)	39,074
Cash at beginning of period	49,801	5,745
Cash at end of period	$ 6,872	$ 44,819